Answer
The Tillomed Laboratories Ltd treosulfan 5 g powder for solution for infusion product is indicated for palliative treatment of advanced epithelial ovarian cancer after at least one line of standard therapy.
Sources for this answer
- Treosulfan 5g Powder for Solution for InfusionTillomed Laboratories Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 5Document updated
Sources checked